EXELIXIS, INC. (EXEL): SEC Filings & AI Analysis
Healthcare. Latest 10-K, 10-Q, and 8-K filings for EXELIXIS, INC. (EXEL) with AI risk scoring and cited answers, grounded in primary-source SEC EDGAR data.
Most recent filing — 8-K filed September 11, 2026: CAUTIOUS Concern level: HIGH.
Company overview — key questions
Answers are generated from SEC filings and StockHuntr's analysis. Not investment advice.
What is EXELIXIS, INC. (EXEL)?
EXELIXIS, INC. is a publicly traded company in the Healthcare space tracked on StockHuntr, which analyzes its SEC filings (10-K, 10-Q, 8-K) and generates 30-day stock predictions.
What are EXEL's most recent SEC filings?
Recent filings: 8-K (September 11, 2026), 8-K (August 31, 2026).
What does EXEL's latest filing analysis show?
EXEL's most recent 8-K (September 11, 2026) is rated CAUTIOUS, concern level HIGH.
Is EXEL a buy?
StockHuntr doesn't issue buy or sell ratings — it's a research tool. For EXELIXIS, INC. (EXEL), its latest 8-K is rated HIGH concern. Weigh these filing-based signals alongside your own research. This is model analysis for research, not investment advice.
Other Healthcare companies
About this analysis
- Primary source:
- View this company's filings on SEC EDGAR
- Additional data:
- Yahoo Finance (market data)
- Method:
- StockHuntr analyzes filings with AI — see our methodology.
- Analysis as of:
- September 11, 2026
- Published by:
- StockHuntr
For research and education only. Nothing here is investment advice.
Loading EXEL snapshot...
Fetching live market data